Publizoom

Swedisch Orphan Biovitrum GmbH

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won
1
Amount won alone
€216,000 excl. VAT
Period
29 September 2026 – 29 September 2026

Its main clients

Where and what

Supplies · 1

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned endContractCurrent holderAmount
31 August 2028
re-tender around March 2028
Arzneimittelrabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Efmoroctocog alfa sowie zum Wirkstoff Efanesoctocog alfa
AOK Baden-Württemberg framework agreement
Swedisch Orphan Biovitrum GmbH
1 bid received
€216,000

Contracts won

DateContractBuyerAmount
29/09/2026 Arzneimittelrabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Efmoroctocog alfa sowie zum Wirkstoff Efanesoctocog alfa AOK Baden-Württemberg €216,000

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.